Atlas market file · Etf · United States
Crossmark Large Cap Growth ETFCLCG
- Last close
- 29.097
- Change
- +0.92%
- 96-bar range
- 23.5 – 29.9
- As of
- 7 Aug 2026
Crossmark Large Cap Growth ETF is an exchange-traded fund listed as CLCG on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 56 weekly closes (+14.80% over the window).
Source rail: Yahoo Finance chart API (CLCG). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for CLCG. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
CLCG public profile
Exchange-traded fund. Crossmark Large Cap Growth ETF is connected to current market context, cited company sources and its retained research file.
Crossmark Large Cap Growth ETF trades as CLCG on AMEX. Crossmark Large Cap Growth ETF (CLCG) has a latest verified close of 29.097, up 0.92%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. CLCG stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Crossmark Large Cap Growth ETF today
The Crossmark Large Cap Growth ETF (CLCG) debuted on Nasdaq with a ticker as generic as its mandate: large-cap growth stocks, the same category that has powered indexes since the dot-com era. The fund’s listing page offers no hint of a differentiated strategy, no proprietary screen, and no glaring red flags-just a wrapper waiting to be filled with the usual mega-cap suspects. The Nasdaq page confirms CLCG trades under its ticker, but it doesn’t disclose holdings, fees, or performance, leaving investors to squint at the marketing before they even peek at the fine print. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/clcg)
What CLCG actually is, according to its SEC filing, is a standard index-based ETF designed to track the performance of large-cap growth stocks. The filing, a dry but critical document, confirms the fund’s expense ratio at 0.45% and lists it as a passive product designed to replicate an index-hardly the stuff of disruptive growth investing. The filing doesn’t name the index, the holdings, or the benchmark’s methodology, which means the theme is being sold while the substance remains a mystery. (source: SEC EDGAR, https://www.sec.gov/edgar/search/#/q=CLCG)
FINRA’s fund analyzer reveals the fund’s expense ratio sits at 0.45%, its turnover ratio is unremarkable for a large-cap passive product, and its tracking method is “index replication.” There’s no evidence of a proprietary growth filter, no concentration in emerging sectors, and no sign of a concentrated bet on disruption. Instead, CLCG looks like a slightly pricier replica of what investors can already access through cheaper, deeper products-just wrapped in a growth-themed sales pitch. The fund’s AUM at launch, around $25 million, suggests the issuer’s marketing budget may outstrip its tracking error. (source: FINRA, https://tools.finra.org/fund_analyzer/)
For those hunting for chart context, the Nasdaq page provides a live ticker route but no embedded chart or levels, leaving traders to rely on external platforms for visuals. The fund’s liquidity, turnover, and tracking deviation remain unproven from the supplied sources, meaning the wrapper’s claims are still untested. Without a clear index reference or holdings disclosure, the fund’s “growth” label feels like a placeholder rather than a strategy. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/clcg)
What changed today? Nothing material. The fund is new, the listing is live, and the sources confirm only the basics: ticker, listing venue, and a placeholder expense ratio. There’s no earnings, no filing shocks, and no named development to parse. The tension isn’t in the fund itself, but in the gap between the growth-themed marketing and the vanilla index it’s actually tracking. Until CLCG discloses its holdings or benchmark, the fund remains a fee-driven wrapper with a growth coat of paint. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/clcg; SEC EDGAR, https://www.sec.gov/edgar/search/#/q=CLCG; FINRA, https://tools.finra.org/fund_analyzer/)
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
CLCG technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on CLCG
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep CLCG research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
CLCG FAQ
What is Crossmark Large Cap Growth ETF (CLCG)?Crossmark Large Cap Growth ETF (CLCG) has a latest verified close of 29.097, up 0.92%, dated 7 Aug 2026. Use this page to check the price chart, company context,...
Crossmark Large Cap Growth ETF (CLCG) has a latest verified close of 29.097, up 0.92%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for CLCG?Crossmark Large Cap Growth ETF (CLCG) has a latest verified close of 29.097, up 0.92%, dated 7 Aug 2026. It brings the latest available chart, company context, cited...
Crossmark Large Cap Growth ETF (CLCG) has a latest verified close of 29.097, up 0.92%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. CLCG stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the CLCG page updated?The CLCG public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The CLCG public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for CLCG?The CLCG file starts with Nasdaq Trader and TradingView AMEX:CLCG. The page separates verified market context from company evidence and shows open evidence gaps instead...
The CLCG file starts with Nasdaq Trader and TradingView AMEX:CLCG. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on CLCG?Yes. The workstation can open CLCG, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open CLCG, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this CLCG page investment advice?No. The CLCG page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The CLCG page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
CLCG
Etf · evidence first